Ciprofloxacin
Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pn…
United States
$17
per month
India
$0
per month
You save
−99.82%save $17/mo · 99.82% cheaper
4.9M US scripts/yr$80.7M potential annual savings$80.9M US spend/yr
Drag to rotate · 3D structureC17H18FN3O3
SMILES: C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
Compare the price
US price$17per month
India price$0per month
You save$1799.82% less
Based on 30 units per month. US $0.55 vs India $0.00 per unit.
Total over 1 periodSave $17$17 → $0
The bigger picture
Ciprofloxacin is filled about 4.9M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$80.9M
If sourced from India
$145.9K
Potential annual savings
$80.7M
−100%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.